acth
Acth (Corticotropin) is an adrenocorticotropic hormone used to treat Collagen Diseases, Erythema Multiforme, Multiple Sclerosis, Nephrotic Syndrome.
Corticotropin · by Parkedale
Key facts
- Active ingredient
- Corticotropin
- Drug class
- Adrenocorticotropic Hormone
- Form
- Injectable
- Strength
- Corticotropin 25 UNITS/VIAL · Corticotropin 40 UNITS/VIAL
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Parkedale
- FDA application
- NDA008317
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
- collagen diseases
- erythema multiforme
- multiple sclerosis
- nephrotic syndrome
- optic neuritis
- rheumatic diseases
See how Acth ranks — best-rated adrenocorticotropic hormone for:
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Acth treat?
- Acth (Corticotropin) may be used to treat collagen diseases, erythema multiforme, multiple sclerosis, nephrotic syndrome, optic neuritis, rheumatic diseases, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Acth?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Acth. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Acth?
- Acth is marketed by Parkedale. You can see Parkedale's full profile, rating, and other products on pharmaranks.
- Is Acth a brand-name or generic drug?
- Acth is a brand-name product with the active ingredient Corticotropin.
- Is Acth available over the counter?
- No. Acth is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Acth come in?
- Acth is currently marketed as injectable, per the FDA's National Drug Code Directory.
- What class of drug is Acth?
- Acth is classified as adrenocorticotropic hormone, per the FDA's Established Pharmacologic Class.
- Is Acth FDA-registered?
- Acth is on record with the U.S. FDA under application number NDA008317. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about CORTICOTROPIN
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 15,875 reports naming CORTICOTROPIN — the active ingredient in Acth, and the FDA flagged 44% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- fatigue1,437 reports
- injection site bruising1,286 reports
- insomnia1,078 reports
- injection site pain1,004 reports
- headache920 reports
- weight increased916 reports
- blood glucose increased712 reports
- peripheral swelling698 reports
Read these as a signal, not a rate. A report does not mean CORTICOTROPIN caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Acth head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
acth
New